Astrazeneca receives positive feedback for Moventig
26th Sep 2014 12:36
Astrazeneca shares strained higher on Friday after the company received positive feedback for Moventig, its new treatment for opioid-induced constipation. The committee for Medicinal Products for Human Use of the European Medicines Agency said it had formed a positive opinion on the drug, which has
Read moreLondon midday: Stocks drop as US Treasury acts to block tax inversion deals
23rd Sep 2014 12:38
UK stocks were firmly lower come midday, tracking overnight losses on Wall Street, with investors apparently reacting the US Treasury's move last night to make corporate tax inversions more difficult. Acting as a backdrop, traders were monitoring the first coalition airstrikes against Islamic State
Read moreUS crackdown on tax inversions, AstraZeneca and Shire hit
23rd Sep 2014 11:34
Pharmaceutical companies Shire and AstraZeneca sold off sharply this morning after the US Treasury announced a stricter crackdown against "tax inversion" deals than had been expected. Inversion deals are takeovers designed to reduce the amount of tax US companies pay by moving their headquarters off
Read moreAstrazeneca and Eli Lilly to develop Alzheimer's drug
16th Sep 2014 07:44
Astrazeneca has agreed to jointly develop and commercialise AZD3293, a drug currently being tested as a potential treatment for Alzheimer's disease, with Eli Lilly. Lilly will pay Astra up to $500m in development and regulatory milestone payments, the first of which it expects to receive in the firs
Read moreLondon close: Tesco and HSBC focus investors' attention
1st Sep 2014 17:21
- Chinese, Eurozone and UK manufacturing PMIs fall - Markets looking ahead to BoE, ECB, US jobs data - Perform jumps on Access Industries offer techMARK 2,858.54 +0.26% FTSE 100 6,825.31 +0.08% FTSE 250 15,957.13 +0.45% Figures showing a manufacturing slowdown in the Eurozone, UK and China capped
Read moreLondon close: FTSE ends higher after data-heavy day
29th Aug 2014 17:23
- FTSE 100 closes up 13.95 at 6,819.75 - UK consumer confidence up - House prices inch higher techMARK 2,851.08 +0.17% FTSE 100 6,819.75 +0.20% FTSE 250 15,885.72 -0.16% The biggest London-listed stocks ended the week on an upbeat note after data-heavy session around for the UK, the Eurozone and t
Read moreFTSE 100 movers: Supermarkets provide drag after Tesco issues profit warning
29th Aug 2014 15:46
Shares in Tesco fell sharply on Friday after the supermarket giant announced it expects profits to fall by as much as 27% this year and its interim dividend to be cut by 75%. New boss Dave Lewis, who due to take over from Philip Clarke, will now join the group one month earlier than planned on 1 Sep
Read moreLondon open: FTSE tracks gains in US
26th Aug 2014 09:26
- Jackson hole comments drive gains - S&P 500 surpasses 2,000 - Bunzl, WPP gain techMARK 2,828.25 +0.18% FTSE 100 6,800.64 +0.37% FTSE 250 15,924.69 +0.27% London's blue chips delivered decent gains on Tuesday morning as they followed in the steps of US stocks, which on Monday night were driven hi
Read moreFTSE 100 movers: Miners slide as Astra gains on bid speculation
21st Aug 2014 18:01
Mining stocks led the downside after metals consumer China disappointed with its manufacturing data and metal prices fell. Fresnillo, Randgold Resources, Anglo American, Rio Tinto and BHP Billiton all fell into the red. BHP was still under pressure in the aftermath of Tuesday's underwhelming plans
Read moreSector movers: Astrazeneca boosts pharma stocks on Pfizer return hopes
21st Aug 2014 17:48
Astrazenca was leading the pharmaceuticals sector higher on Thursday on the back of speculation that US drug giant Pfizer could return with a fresh offer in the coming days. The reports lifted others in the sector higher in afternoon trading with peers such as Glaxosmithkline, Hikma and BTG making
Read moreLondon close: Astrazeneca leads FTSE higher on bid speculation
21st Aug 2014 17:42
- Healthcare stocks lift FTSE - German PMI data drives sentiment - Investors look ahead to Draghi speech - UK retail sales disappoint techMARK 2,819.77 +0.82% FTSE 100 6,777.66 +0.33% FTSE 250 15,838.57 +0.57% London's blue chips ended Thursday's session on a positive note, led by Astrazeneca. Inc
Read moreLondon midday: UK stocks advance as investors shrug off weak data
21st Aug 2014 12:01
- Mining stocks fall as Chinese data weakens - Eurozone PMIs and UK retail sales disappoint - US data, Jackson Hole ahead techMARK 2,810.76 +0.50% FTSE 100 6,772.04 +0.25% FTSE 250 15,797.15 +0.31% Falls in the heavyweight mining sector weren't enough to stop the FTSE 100 from advancing on Thursda
Read moreAstraZeneca relief as US DoJ closes investigation into Brilinta
19th Aug 2014 08:37
A US Department of Justice investigation into clinical trials carried out by AstraZeneca has been closed with no further action to be taken. Astra underwent investigation into its 'Plato' trials of heart drug Brilinta in October 2013, with media speculation that this was due to inaccurate results b
Read moreAstrazeneca progresses with treatment for antibioitc-resistant infections
19th Aug 2014 08:35
Astrazeneca has reported progress in studies of its antibiotic drug that could be used in hospitalised adult patients with complicated intra-abdominal infections. The studies into ceftazidime-avibactam (CAZ-AVI), known as reclaim-1 and reclaim-2, are examining whether the combination of a new gener
Read moreAstraZeneca starts phase III of asthma drug Tralokinaums
14th Aug 2014 08:43
Pharmaceutical giant AstraZeneca has started phase III of its asthma control medicine, Tralokinaums, in an effort to strengthen its respiratory portfolio. Phase three of the programme will see the group assess the safety of its newly designed treatment, made by its research division MedImmune. Tr
Read more